Company Filing History:
Years Active: 2001-2004
Title: The Innovative Contributions of Karen S Moulton
Introduction
Karen S Moulton is a prominent inventor based in Weston, MA (US). She has made significant contributions to the field of medical treatments, particularly in cardiovascular health. With a total of 2 patents, her work focuses on innovative methods to address critical health issues.
Latest Patents
Moulton's latest patents include a method of treatment for cardiovascular injuries. This invention provides a systematic approach to treating cardiovascular ailments by screening individuals for the risk of unstable plaques. The criteria for selection include increased plaque neovascularization, area ratio of intima to wall area of a plaque, evidence of plaque hemorrhage, and inflammatory cells associated with plaque vessels. By identifying individuals with the potential for unstable plaques, the method allows for targeted treatment using an effective amount of an angiogenesis inhibitor.
Another significant patent addresses the treatment of chronic allograft rejection with anti-angiogenic agents. This invention outlines a method for inhibiting chronic allograft rejection in organ transplant recipients. It involves administering an effective amount of one or more anti-angiogenic agents, either alone or in combination with immunosuppressive agents. This innovative approach provides new and improved methods for managing allograft rejection.
Career Highlights
Karen S Moulton is affiliated with the Children's Medical Center Corporation, where she continues to advance her research and innovations in medical treatments. Her work has garnered attention for its potential to improve patient outcomes in critical health scenarios.
Collaborations
Moulton has collaborated with notable figures in her field, including Judah M Folkman and David M Briscoe. These partnerships have contributed to the development and refinement of her innovative methods.
Conclusion
Karen S Moulton's contributions to medical innovation, particularly in cardiovascular treatment, highlight her role as a leading inventor in her field. Her patents reflect a commitment to improving health outcomes through targeted therapies.